v3.26.1
Description of the Business and Financial Condition (Details) - USD ($)
 1 Months Ended 2 Months Ended 3 Months Ended 12 Months Ended
Feb. 28, 2026
Jun. 30, 2025
Jan. 31, 2025
Mar. 31, 2026
Mar. 31, 2026
Mar. 31, 2025
Dec. 31, 2025
Sep. 30, 2025
Jun. 30, 2024
Subsidiary, Sale of Stock [Line Items]                  
Accumulated deficit       $ (245,495,000) $ (245,495,000)   $ (233,672,000)    
At-the-market offering costs incurred but not paid included in accrued expenses and accounts payable         150,000 $ 0      
Cash and cash equivalents       $ 14,948,000 $ 14,948,000 $ 18,351,000 $ 18,563,000    
Senior Secured Convertible Promissory Note                  
Subsidiary, Sale of Stock [Line Items]                  
Number of shares of common stock to purchase (up to) (in shares)   103,225           103,225  
Exercise price (in dollars per share)   $ 7.75              
Warrants, contractual term (in years)   5 years              
Debt instrument, face amount   $ 10,000,000.0              
Proceeds from issuance of long-term debt   $ 9,900,000              
January Common Warrants                  
Subsidiary, Sale of Stock [Line Items]                  
Issuance of common stock, net of issuance costs (in shares)     1,261,830            
Number of shares of common stock to purchase (up to) (in shares)     1,261,830            
Warrants, contractual term (in years)     5 years            
Common Stock                  
Subsidiary, Sale of Stock [Line Items]                  
Proceeds from issuance of common stock     $ 9,200,000            
Common Stock | January Common Warrants                  
Subsidiary, Sale of Stock [Line Items]                  
Share price (in dollars per share)     $ 7.925            
Exercise price (in dollars per share)     $ 7.80            
Proceeds from issuance of common stock     $ 9,200,000            
2024 Registration Statement                  
Subsidiary, Sale of Stock [Line Items]                  
Sale of stock, aggregate initial offering price                 $ 200,000,000
At-The-Market Equity Offering Sales Agreement 2024                  
Subsidiary, Sale of Stock [Line Items]                  
Sale of stock, aggregate initial offering price                 $ 40,000,000
At-The-Market Equity Offering Sales Agreement 2024 | Common Stock                  
Subsidiary, Sale of Stock [Line Items]                  
Shares sold in offering (in shares)         106,823 699,678 1,717,507    
Share price (in dollars per share)       $ 9.52 $ 9.52 $ 7.82 $ 9.46    
Net proceeds         $ 800,000 $ 6,700,000 $ 16,200,000    
2026 Registration Statement                  
Subsidiary, Sale of Stock [Line Items]                  
Sale of stock, aggregate initial offering price $ 400,000,000                
At-The-Market Equity Offering Sales Agreement 2026                  
Subsidiary, Sale of Stock [Line Items]                  
Sale of stock, aggregate initial offering price 100,000,000                
Stock issuance costs         $ 200,000        
At-the-market offering costs incurred but not paid included in accrued expenses and accounts payable $ 200,000                
At-The-Market Equity Offering Sales Agreement 2026 | Common Stock                  
Subsidiary, Sale of Stock [Line Items]                  
Shares sold in offering (in shares)         119,479        
Share price (in dollars per share)       $ 11.42 $ 11.42        
Net proceeds       $ 1,100,000 $ 1,300,000        
At-the-Market Offering                  
Subsidiary, Sale of Stock [Line Items]                  
Stock issuance costs           $ 0      
At-the-Market Offering | Common Stock                  
Subsidiary, Sale of Stock [Line Items]                  
Shares sold in offering (in shares)         819,157        
Share price (in dollars per share)       $ 9.80 $ 9.80        
Net proceeds         $ 7,800,000        
Consideration received net of sales commissions         $ 8,000,000.0        
Issuance of common stock, net of issuance costs (in shares)         819,157 106,823